ceramides - CISMeF

Preferred Label : ceramides;

MeSH definition : Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE.;

MeSH synonym : Ceramide;

MeSH annotation : carbohydrate ceramides: index under CEREBROSIDES (one carbohydrate group) or NEUTRAL GLYCOSPHINGOLIPIDS (more than one carbohydrate group);

Wikipedia link : https://en.wikipedia.org/wiki/Ceramide;

Is substance : O;

Details

Origin ID

D002518;

UMLS CUI

C0007745;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Ceramide [NCIt concept]
- Ceramide (substance) [SNOMED CT concept]
- ceramide [SNOMED Notion]
Indexing information
- fucosylglycolipids [MeSH Supplementary Concept]
Record concept(s)
- ceramides [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2S, 3S, 4R, 20E)-2-((2'R)-2'-hydroxyl-palmitoyl-amino)-20-hexacosene-1, 3, 4-triol [MeSH Supplementary Concept]
- (2S,3R,4E)-2-(14'-methyl-pentadecanoylamino)-4-octadecene-l,3-diol [MeSH Supplementary Concept]
- (2S,3R,4E,8E)-N-hexadecanoyl-2-amino-4,8-octadecadiene-1,3-diol [MeSH Supplementary Concept]
- (3S,4S,5R)-3-((2R)-2-hydroxyhexacosanoylamino)-4-hydroxy-5-((4E)-dodecane-4-ene)-2,3,4,5-tetrahydrofuran [MeSH Supplementary Concept]
- (3S,4S,5R)-3-octadecanoylamino-4-hydroxy-5-dodecane-2,3,4,5-tetrahydrofuran [MeSH Supplementary Concept]
- (E)-N-(1,3,4,5-tetrahydroxyhexadecan-2-yl)dec-4-enamide [MeSH Supplementary Concept]
- (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide [MeSH Supplementary Concept]
- 1,3-dihydroxy-2-((hexadecanoyl)amino)nonadeca-4-ene [MeSH Supplementary Concept]
- 1-O-beta-D-glucopyranosyl-(2S,3S,4R,8E)-2-((2R)-2-hydroxytetracosanoylamino)-1,3,4-octodecanetriol-8-ene [MeSH Supplementary Concept]
- 1-O-beta-D-glucopyranosyl-(2S,3S,4R,9Z)-2-((2R)-2-hydroxydocosanoylamino)-9-octadecene-1,3,4-triol [MeSH Supplementary Concept]
- 1-O-beta-D-glucopyranosyl-(2S,3S,4R,9Z)-2-((2R)-2-hydroxytetracosanoylamino)-1,3,4-octadecanetriol [MeSH Supplementary Concept]
- 1-methylthiodihydroceramide [MeSH Supplementary Concept]
- 2'-hydroxy C16-ceramide [MeSH Supplementary Concept]
- 2,3-dihydroxy-N-((2S,3S,4R)-1,3,4-trihydroxyicosan-2-yl)tetracosanamide [MeSH Supplementary Concept]
- 2-(2'-hydroxy-21'-methyldocosanoylamino)-1,3,4-pentadecanetriol [MeSH Supplementary Concept]
- 2-(2'-hydroxytetracosanoylamino)octadecane-1,3,4-triol [MeSH Supplementary Concept]
- 2-(heptadecanoylamino)heptadeca-4,8-diene-1,3-diol [MeSH Supplementary Concept]
- 2-(hexanoylamino)-5-phenylpent-4-ene-1,3-diol [MeSH Supplementary Concept]
- 2-N-(10-pyrenedecanoyl)-1,3,17-trihydroxy-17-(3,5-dinitrobenzoyl)-4-heptadecene [MeSH Supplementary Concept]
- 2-N-(6'-(1''-pyridinium)hexanoyl)sphingosine [MeSH Supplementary Concept]
- 2-N-(6'-(1'-pyridinium)hexanoyl)sphingosine [MeSH Supplementary Concept]
- 2-acetamido-4-dodecene-1,3-diol [MeSH Supplementary Concept]
- 2-octadecanoylamino-1,3-dihydroxy-octadecene-4 [MeSH Supplementary Concept]
- 2-octanoylamido-4,6-octadecadiene-1,3-diol [MeSH Supplementary Concept]
- 3-deoxyphytoceramide [MeSH Supplementary Concept]
- 3-trifluoromethyl-3-(3-iodophenyl)diazirineceramide [MeSH Supplementary Concept]
- 4,5-epoxy-N-acetylsphingosine [MeSH Supplementary Concept]
- 9-O-MGN-MGN-MGN-IPCA [MeSH Supplementary Concept]
- AGL 529 [MeSH Supplementary Concept]
- AGL 533 [MeSH Supplementary Concept]
- AGL 563 [MeSH Supplementary Concept]
- C12-NBD-ceramide [MeSH Supplementary Concept]
- C2-di-ethyl-ceramide-1-phosphate [MeSH Supplementary Concept]
- C4-methylene D-erythro-N-octanoylceramide [MeSH Supplementary Concept]
- D-erythro-2-N-(160-(1''-pyridinium)hexadecanoyl)sphingosine bromide [MeSH Supplementary Concept]
- EGL-II glycosphingolipid [MeSH Supplementary Concept]
- EpiCeram [MeSH Supplementary Concept]
- Gal-1-3-Lewis(x) hexaglycosylceramide [MeSH Supplementary Concept]
- K112PC-5 compound [MeSH Supplementary Concept]
- N-(1-hydroxy-3-oxoheptadeca-4,6-dien-2-yl)-2-phenylacetamide [MeSH Supplementary Concept]
- N-(4',5'-dithiaheptanoyl)-D-erythro-ceramide [MeSH Supplementary Concept]
- N-(4,4-difluoro-5,7-dimethyl-4--bora-3a,4a-diaza-s-indacene-3-pentanoyl)sphingosine [MeSH Supplementary Concept]
- N-(5-dodecyl-4-hydroxytetrahydrofuran-3-yl)-2-hydroxyheptadecanamide [MeSH Supplementary Concept]
- N-(6-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminohexanoyl)-3-O-methylsphingosine [MeSH Supplementary Concept]
- N-(6-N--(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminohexanoyl)-1-O-methylsphingosine [MeSH Supplementary Concept]
- N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine [MeSH Supplementary Concept]
- N-(alpha-hydroxyoctadecanoyl)phytosphingosine [MeSH Supplementary Concept]
- N-(omega-acyloxy)acylsphingosine [MeSH Supplementary Concept]
- N-butanoylsphingosine [MeSH Supplementary Concept]
- N-caproylsphingosine [MeSH Supplementary Concept]
- N-docosanoyl-16-methylheptadecasphing-4-enine [MeSH Supplementary Concept]
- N-hexanoyldihydrosphingosine [MeSH Supplementary Concept]
- N-lactyldihydrosphingosine [MeSH Supplementary Concept]
- N-lactylsphingosine [MeSH Supplementary Concept]
- N-lauroylsphingosine [MeSH Supplementary Concept]
- N-palmitoylsphingosine [MeSH Supplementary Concept]
- N-stearoylphytosphingosine [MeSH Supplementary Concept]
- N-stearoylsphinganine [MeSH Supplementary Concept]
- N-tetracosanoyl-(L)-serine tetradecyl ester [MeSH Supplementary Concept]
- Nutratopic pro-AMP [MeSH Supplementary Concept]
- PC 104 [MeSH Supplementary Concept]
- PCERA-1 [MeSH Supplementary Concept]
- SLE66 compound [MeSH Supplementary Concept]
- TriCeram [MeSH Supplementary Concept]
- XM 462 [MeSH Supplementary Concept]
- acetyl-C16-ceramide-NBD [MeSH Supplementary Concept]
- armillaramide [MeSH Supplementary Concept]
- asteriaceramide A [MeSH Supplementary Concept]
- bathymodiolamide A [MeSH Supplementary Concept]
- bathymodiolamide B [MeSH Supplementary Concept]
- beta-galactosyl ceramide [MeSH Supplementary Concept]
- bio 391 [MeSH Supplementary Concept]
- cameroonemide A [MeSH Supplementary Concept]
- ceramide 1-phosphate [MeSH Supplementary Concept]
- ceramide N-((2S,3R,4E,6E)-1,3-dihydroxyhenicosa-4,6-dien-2-yl)tridecanamide [MeSH Supplementary Concept]
- ceramide N-methylaminoethylphosphonate [MeSH Supplementary Concept]
- ceramide aminoethylphosphonate [MeSH Supplementary Concept]
- clavaminol A [MeSH Supplementary Concept]
- clavaminol C [MeSH Supplementary Concept]
- clavaminol H [MeSH Supplementary Concept]
- damicoside [MeSH Supplementary Concept]
- dihydroceramide [MeSH Supplementary Concept]
- embelamide [MeSH Supplementary Concept]
- forsskamide [MeSH Supplementary Concept]
- fty720-c2 [MeSH Supplementary Concept]
- halyminine [MeSH Supplementary Concept]
- hemisceramide [MeSH Supplementary Concept]
- iotrochotamide I [MeSH Supplementary Concept]
- iotrochotamide II [MeSH Supplementary Concept]
- isoglobopentaosylceramide [MeSH Supplementary Concept]
- lactariamide A [MeSH Supplementary Concept]
- lactariamide B [MeSH Supplementary Concept]
- oleoylsphingosine [MeSH Supplementary Concept]
- omega-amino-ceramide [MeSH Supplementary Concept]
- palyosulfonoceramide A [MeSH Supplementary Concept]
- palyosulfonoceramide B [MeSH Supplementary Concept]
- parinaramide [MeSH Supplementary Concept]
- phosphoceramide azidothymidine [MeSH Supplementary Concept]
- phosphoceramide didehydrodeoxythymidine [MeSH Supplementary Concept]
- phosphonotetraglycosyl ceramide [MeSH Supplementary Concept]
- sphingolipid E [MeSH Supplementary Concept]
- trametenamide A [MeSH Supplementary Concept]
- trametenamide B [MeSH Supplementary Concept]
See also
- fabry disease [MeSH Descriptor]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Ceramide [NCIt concept]
- Ceramide (substance) [SNOMED CT concept]
- ceramide [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients